EU-MEDICAL_DEVICES_REGULATION-ANX_I_SEC_10
EU-MEDICAL_DEVICES_REGULATION-ANX_I_SEC_10
Medical Devices Regulation - Hazardous Substances
EU. Hazardous Substances for Purposes of Medical Devices Regulation 2017/745/EU, 5 May 2017, as amended by Regulation 2020/561/EU, 24 April 2020
This list contains hazardous substances for purposes of the Medical Devices Regulation (MDR), based on the legislation's Annex I general safety and performance requirements, including for chemical, physical and biological properties. Specifically, the non-exhaustive database is derived from: Table 3 of Annex VI to CLP, REACH Candidate List of SVHCs, and Directive 2000/54/EC's Annex III (Biological Agents list).
Last updated 26 srpnja 2024. Database contains 4917 unique substances/entries.
Filter the list
|
show/hide
|
-
|
-
|
Repr. 1B |
Details | ||
|
-
|
15271-41-7
|
Acute Tox. 2; Acute Tox. 3 |
Details | |||
|
-
|
2532-43-6
|
Acute Tox. 3 |
Details | |||
|
show/hide
|
-
|
-
|
Carc. 1B; Muta. 1B; Repr. 2; Acute Tox. 3 |
Details | ||
|
-
|
-
|
ENDE Endocrine disrupting properties (Article 57(f) - environment) |
Details | |||
|
-
|
-
|
R Toxic for reproduction (article 57c) ENDE Endocrine disrupting properties (Article 57(f) - environment) END Endocrine disrupting properties (Article 57(f) - human health) |
Details | |||
|
-
|
-
|
ENDE Endocrine disrupting properties (Article 57(f) - environment) |
Details | |||
|
-
|
-
|
ENDE Endocrine disrupting properties (Article 57(f) - environment) |
Details | |||
|
-
|
-
|
ENDE Endocrine disrupting properties (Article 57(f) - environment) |
Details | |||
|
-
|
51-14-9
|
Acute Tox. 4 |
Details | |||
|
-
|
-
|
VPVB very Persistent and very Bioaccumulative (article 57e) |
Details | |||
|
-
|
-
|
VPVB very Persistent and very Bioaccumulative (article 57e) |
Details | |||
|
-
|
-
|
VPVB very Persistent and very Bioaccumulative (article 57e) |
Details | |||
|
-
|
10027-06-2
|
Acute Tox. 4; Skin Irrit. 2; Skin Sens. 1 |
Details | |||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
Details | |||
|
-
|
-
|
P Parasites |
Details | |||
|
-
|
-
|
B Bacteria and similar species |
Details | |||
|
-
|
-
|
B Bacteria and similar species |
Details | |||
|
-
|
-
|
B Bacteria and similar species |
Details | |||
|
-
|
-
|
B Bacteria and similar species |
Details | |||
|
-
|
-
|
B Bacteria and similar species |
Details | |||
|
-
|
-
|
B Bacteria and similar species |
Details | |||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
Details | |||
|
-
|
-
|
E Equivalent level of concern having probable serious effects to the environment (Article 57(f) - environment) HH Equivalent level of concern having probable serious effects to human health (Article 57(f) - human health) |
Details | |||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
Details | |||